Physician profile
Vivan Shah
NPI 1922592880
$4,694.89
in general payments reported to CMS, 2019-2025
16 companies · $15.23 in 2025
The $15.23 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $27.74 · 2021: $30.00 · 2022: $425 · 2023: $4,197 · 2025: $15.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,211 · Education: $1,016 · Food and Beverage: $985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,211.10 |
| Education | $1,016.15 |
| Food and Beverage | $984.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,956.86 | 2023 | Senza |
| Medtronic, INC. | $1,701.08 | 2023 | Vanta Adaptivestim, Intellis Adaptivestim |
| Vertos Medical, INC. | $181.32 | 2023 | Mild Device Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $115.54 | 2022 | |
| Abbott Laboratories | $112.50 | 2023 | Proclaim |
| Boston Scientific Corporation | $105.66 | 2023 | Wavewriter Alpha Prime 16 |
| Relievant Medsystems, INC. | $96.67 | 2023 | Intracept |
| Spr Therapeutics, INC | $42.53 | 2023 | Sprint Pns System |
| Merz Pharmaceuticals, LLC | $41.80 | 2022 | |
| Abbvie INC. | $33.19 | 2022-2025 | |
| Radius Health, INC. | $16.52 | 2021 | |
| Allergan, INC. | $15.81 | 2020 | |
| Collegium Pharmaceutical, INC. | $13.48 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $11.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivan Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.